The pilot program will run from July 1, 2026, through December 31, 2027
Our medically supervised 21-day program addresses every factor driving your GLP-1 plateau simultaneously and in real time
The calibration and validation results for all cases are included in the Supplementary Information
Although there were some initial concerns, increased rates of pancreatitis or pancreatic cancer have not been seen in meta-analysis
Biosynthesis of a central intermediate in hydrogen sulfide metabolism by a novel human sulfurtransferase and its yeast ortholog
The dataset included formal low blood pressure diagnoses, systolic blood pressure readings dropping below 90 mm Hg, new prescriptions for hypotension drugs, and sudden episodes of dizziness, lightheadedness, fainting, and physical falls